Vifor
RETACRIT
Manufacturer:
Vifor
Name:
RETACRIT
HCPCS Code Descriptor:
Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units
Category:
Q Code
HCPCS:
Q5106
NDC(s):
59353-0220-10, 59353-0220-01, 59353-0120-10, 59353-0004-10, 59353-0010-10, 59353-0120-01, 59353-0003-10, 59353-0002-10, 00069-1318-10, 00069-1311-10, 00069-1309-04, 00069-1308-10, 00069-1307-10, 00069-1306-10, 00069-1305-10
Primary Type:
Oncology Biosimilar
Generic Status:
Multi-Source
Route of Administration:
Subcutaneous
About:
RETACRIT is an Oncology Biosimilar drug manufactured by Vifor and administered via the Subcutaneous route of administration. The Q Code: Q5106 is aligned to the drug RETACRIT.